Category Medicine and Healthcare
Press Release
AI-Powered Transformation Provides Immediate ROI and Drives Hospital C-Suite Innovation With 8 Key Benefits, Black Book Survey Reports
Advanced AI Solutions Provide Measurable Short-Term ROI, Strategic Decision-Making Benefits and Operational Improvements; New Survey Highlights Leading AI Healthcare Vendors Based on Client Satisfaction and Outcomes Read More
Press Release
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction
New data from Eurofins Discovery show that Telomir-1 blocks enzymes that drive disease by turning off critical genes-highlighting its potential to treat cancer, autoimmune conditions, neurodegeneration, and metabolic disorders through epigenetic modulation. Read More
Press Release
Massachusetts Cannabis Contamination Crisis Exposes Federal Negligence While DEA Targets Science, Not Safety
Where Is the DEA? The Real Threat Isn't Research-It's Rotten Weed. "This is the height of hypocrisy," said Duane Boise, CEO MMJ. "DEA bureaucrats are blocking clean cannabis grown in a DEA inspected cultivation facility, while contaminated products circulate freely under their watch. The agency has abandoned its duty to protect patients." Read More
Press Release
Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update
NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque psoriasis (PsO) submitted to U.S. FDA in July ANTHEM Phase 2b trial data of icotrokinra in ulcerative colitis scheduled for an oral presentation at the 33rd United European Gastroenterology Week (UEGW) on October 7th Phase 3 VERIFY trial data set of rusfertide in polycythemia vera (PV) presented during plenary session at ASCO; U.S. NDA filing on track for Q4 Cash, cash equivalents and marketable securities of $673.0 million as of June 30, 2025, anticipated to provide cash runway through at least end of 2028 Read More
Press Release
Electromedical Technologies, Inc. (OTC: EMED) Provides Mid-Year Update Highlighting Financial Restructuring, Regulatory Alignment, and Strategic Progress
Electromedical Technologies (OTC: EMED) outlines key financial restructuring milestones, upcoming product updates, and new strategic partnerships to drive sustainable growth in the pain management market. Read More
Press Release
Will DEA Cole Dismantle Marijuana Research Blockade - MMJ Biopharma Will Be His First Test Case
Terry Cole's future as DEA Administrator depends on recognizing the difference between cartels trafficking illicit fentanyl and MMJ's BioPharma Cultivation developing FDA sanctioned cannabinoid medicines for neurological diseases. Read More
Press Release
Waymark Signal Achieves 85% Accuracy in Predicting Medicaid Care Gaps, Study in npj Digital Medicine Shows
Peer-reviewed research demonstrates dramatic improvement in identifying and closing quality gaps for Medicaid patients, outperforming current methods by 35 percentage points Read More
Press Release
CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitope Phase 1 study in adults with active and chronic active renal allograft AMR planned to initiate AMR is a leading cause of kidney transplant loss, leading to dialysis and/or repeat renal transplant Read More
Press Release
Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery
-Company closes approximately $5.47 million in equity financing in 2Q/3Q25 -TH104 potentially fills a critical National Security Need against Weaponized Fentanyl -TH023 may fulfill the promise of delivering a safe and effective oral antibody medication against inflammation -Company Strengthens Operational Leadership, Corporate Governance and Accounting Read More
Press Release
Will DEA's War on Cannabis Research Claims Another Casualty?
From Dr. Lyle Craker, University of Mass. to Duane Boise, CEO of MMJ BioPharma Cultivation; Dr. Craker died still waiting for the DEA to embrace cannabis science. The same cannot be allowed to happen to MMJ BioPharma Cultivation, whose FDA Multiple Sclerosis and Huntington's Disease clinical trials could bring relief to patients suffering from incurable neurological disorders. Read More
Press Release
DEA Accountability as Cannabis Research Crisis Deepens And Patients Suffer
With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. MMJ International Holdings Issues Clarification on Irvine Labs. Read More
Press Release
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 projected revenue range to $1.5 to $2.2 billion, reflecting a $300 million reduction at the high end, primarily driven by timing of deliveries for contracted revenue into the first quarter of 2026 Improves 2025 expected GAAP operating expenses by approximately $400 million to a range of $5.9 to $6.1 billion Reiterates 2025 expected year-end cash balance of approximately $6 billion Announced three recent U.S. FDA approvals and positive Phase 3 efficacy results for seasonal influenza vaccine Read More
Press Release
Is DEA Administrator Terry Cole Just Another Anti Marijuana Crooner in A Suit? Or A Cannabis Policy Reformer
Newly confirmed DEA Administrator Terrance Cole faces a defining choice: Will he break ranks with the agency's deeply entrenched anti-cannabis cabal-or will he become just another DEA figurehead parroting the same tired "gateway drug" propaganda while Americans suffer, science stalls, and corruption thrives? The public, the scientific community, and thousands of patients are watching-and the window for Cole to make a meaningful impact is rapidly closing. Read More
Press Release
Rapha Dental Welcomes New Patients in Maple Shade and Riverton Areas Amid Recent Local Office Closures
Professional & Friendly: Now accepting new patients with short wait times and personalized care near Maple Shade and Riverton Community-Oriented: Local dental office steps up to serve patients after recent practice closures in the area Value-Focused: Gentle, affordable, and timely dental care available just minutes from Maple Shade and Riverton Read More
Press Release
LeBron James Legally Sourced Miami Heat NBA Finals Jersey Sells for $242K as MDCE's Infinite Auctions Leads Industry Clean-Up
As the sports memorabilia world confronts fraud and chaos, Infinite Auctions (OTC Pink:MDCE) delivers ironclad provenance and authenticity-led by the $242,400 sale of a LeBron James Miami Heat NBA Finals jersey sourced directly from Upper Deck and LeBron James. Read More
Press Release
The Longevity Centers of America Bringing Natural Wellness and Regenerative Care to Greenville, South Carolina
With the opening of a new clinic, The Longevity Centers of America is expanding its signature blend of natural healing and modern wellness therapies into the greater Greenville region. Read More
Press Release
Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement
First sublingual pre-workout single-serving supplement that delivers 50mg of caffeine rapidly to the body, is now available to order via Aspire's new direct-to-consumer shopping experience Read More
Press Release
Ensysce Biosciences Advances Breakthrough Opioid With Built-In Overdose Protection Following Positive FDA Feedback
~ Productive FDA Meeting Highlights Path Toward Overdose Protection Labeling and 505(b)(2) Regulatory Strategy ~ ~ FDA and Ensysce Aligned on Collaborative Approach to Ensure Product's Full Safety Benefits are Recognized ~ Read More
Press Release
Future-Ready EHR Solutions Prioritized by Small Hospitals Amid Financial and Cybersecurity Challenges: Vendor Rankings Announced Based on Black Book 2026 Survey of Small Hospitals
Pressured by Cost, Aging Systems, and Workflow Misalignment, Under-50-Bed Hospitals Indicate an Acceleration Toward Next-Generation EHR Transitions Read More
Press Release